Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

Revenue projections:

Revenue projections for SUVENPHAR
Revenue projections for SUVENPHAR

SUVENPHAR's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.0
forwardPE 0.0
debtToEquity 0.0
earningsGrowth 0.0
revenueGrowth 0.0
grossMargins 0.0
operatingMargins 0.0
trailingEps 0.0
forwardEps 0.0


Price projections:

Price projections for SUVENPHAR
Price projections for SUVENPHAR

SUVENPHAR's present price, in relation to projections, does not offer clear risks or opportunities. This stable scenario suggests a period of consolidation, where investors might prefer to hold off on significant changes in strategy.

Recommendation changes over time:

Recommendations trend for SUVENPHAR
Recommendations trend for SUVENPHAR


Analysts have maintained a buy bias for Suven Pharmaceuticals Limited, which could prompt investors to consider the stock as a viable investment. With this positive outlook, Suven Pharmaceuticals Limited is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.